This free online seminar discusses the challenges of implementing new concepts and technologies in the organic synthesis lab, their acceptance by chemists, and how a sustainable increase of productivity can be attained. Case studies from major pharmaceutical companies highlight the successful implementation of the new synthetic chemistry concepts and technologies.
Major pharmaceutical companies, such as Johnson & Johnson, Pfizer, and Novartis, are moving towards a new generation of personal synthesis workstations that are easier to use and support a broader range of applications than current instrumentation. Ultimately, they also provide more and better information with fewer experiments, enabling chemists to be more productive. |
 Preview the On-Demand Webinar |
Webinar Presenter
Your online presenter, Francis van der Eycken, Head of Innovations at METTLER TOLEDO, is an organic chemist and has previously worked in the process chemistry department at Janssen Pharmaceutica (a Johnson & Johnson company) for 12 years for in various positions.
Related topics
synthetic chemistry, Johnson & Johnson, J&J, Janssen Pharmaceutica, Pfizer, Novartis, personal synthesis workstation, organic synthesis, organic chemistry, organic chemists, synthetic organic chemists, chemical development, lab reactors, synthesis reactor, process screening, EasyMax